Deciphering the mechanism of cimifugin in mitigating LPS-induced neuroinflammation in BV-2 cells
Allergologia et Immunopathologia · 2024
DOI: 10.15586/aei.v52i4.1107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2024. Verfasst von Zhang Bu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Lipopolysaccharides, Oxidative Stress, Microglia, Cytokines. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Sepsis often triggers a systemic inflammatory response leading to multi-organ dysfunction, with complex and not fully understood pathogenesis. This study investigates the therapeutic effects of cimifugin on BV-2 cells under sepsis-induced stress conditions.
Methods
We utilized a BV-2 microglial cell model treated with lipopolysaccharide (LPS) to mimic sepsis. Assessments included cellular vitality, inflammatory cytokine quantification (6 interleukin [6IL]-1β, interleukin 6 [IL-6], and tumor necrosis factor-α [TNF-α]) via enzyme-linked-immunosorbent serologic assay, and analysis of mRNA expression using real-time polymerase chain reaction. Oxidative stress and mitochondrial function were also evaluated to understand the cellular effects of cimifugin.
Results
Cimifugin significantly attenuated LPS-induced inflammatory responses, oxidative stress, and mitochondrial dysfunction. It enhanced cell viability and modulated the secretion and gene expression of inflammatory cytokines IL-1β, IL-6, and TNF-α. Notably, cimifugin activated the deacetylase sirtuin 1–nuclear factor erythroid 2-related factor 2 pathway, contributing to its protective effects against mitochondrial damage.
Conclusion
Cimifugin demonstrates the potential of being an effective treatment for sepsis--induced neuroinflammation, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Soochow University Campus Hospital, Soochow University, Suzhou, Jiangsu, China.
- Department of Emergency Medicine, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; xufeng_668@163.com.
Zitieren
APA
Bu, Z., Xu, S., & Xu, F. (2024). Deciphering the mechanism of cimifugin in mitigating LPS-induced neuroinflammation in BV-2 cells. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v52i4.1107
Vancouver
Bu Z, Xu S, Xu F. Deciphering the mechanism of cimifugin in mitigating LPS-induced neuroinflammation in BV-2 cells. Allergologia et Immunopathologia. 2024. doi:10.15586/aei.v52i4.1107
BibTeX
@article{Bu2024,
author = {Bu, Zhang and Xu, Shan and Xu, Feng},
title = {Deciphering the mechanism of cimifugin in mitigating LPS-induced neuroinflammation in BV-2 cells},
journal = {Allergologia et Immunopathologia},
year = {2024},
doi = {10.15586/aei.v52i4.1107}
}
EUVIMED